US Stock MarketDetailed Quotes

PSTX Poseida Therapeutics

Watchlist
  • 3.060
  • +0.090+3.03%
Close May 22 16:00 ET
296.69MMarket Cap-2615P/E (TTM)

Poseida Therapeutics Key Stats

Poseida Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

28.14M

+172.09%
EPS(YoY)

-0.25

+44.44%

Strong Buy

Apr 30, 2024

Poseida Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 18.750M--
--2024/Q2-- / 18.750M--
--2024/Q128.142M / 11.667M--
--2023/Q424.995M / 6.650M--
--2023/Q39.352M / 18.867M--
--2023/Q220.013M / 5.085M--
--2023/Q110.343M / 3.333M--
--2022/Q410.051M / 31.750M--
--2022/Q3116.306M / 833.330K--
--2022/Q22.700M / 933.330K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 18.750M--
--2024/Q2-- / 18.750M--
--2024/Q128.142M / 11.667M--
--2023/Q424.995M / 6.650M--
--2023/Q39.352M / 18.867M--
--2023/Q220.013M / 5.085M--
--2023/Q110.343M / 3.333M--
--2022/Q410.051M / 31.750M--
--2022/Q3116.306M / 833.330K--
--2022/Q22.700M / 933.330K--

Unlock Free Earnings Estimates

Poseida Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Apr 30, 2024

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg